Bronkhorst opens new UK premises

Published: 23-Nov-2010
Manufacturing Finance Analysis

Move to Newmarket offers scope for expansion

Fluid metering and control instrumentation specialist Bronkhorst UK has completed a move to new premises in Newmarket, UK.

A wholly owned subsidiary of Bronkhorst High-Tech BV of Holland, the company was established in Sawston, Cambridgeshire in 2002, since when it claims to have increased turnover by 800%.

Having outgrown its original headquarters, the company has relocated to Newmarket in order to have room for future expansion and gain access to the local pool of skilled labour. There are plans to double the workforce within the next five years.

To mark the occasion, Councillor Mick Jeffrys, the Mayor of Newmarket, performed the official opening. Special guests included the joint founders and co-owners of Bronkhorst, Teus Bruggemann and Wybren Jouwsma, who have invested substantially in growing the UK operation and have a policy of investing around 15% of group annual turnover on r&d.

Bronkhorst UK’s managing director Andrew Mangell, said: ‘We have grown rapidly in terms of both sales revenue and staff numbers, even maintaining an upward trend during the recession, and our new Newmarket base gives us more valuable floorspace, good links with the travel network and a superb quality of environment.’

Bronkhorst claims to supply virtually every customer sector in the UK, taking in laboratory, university, industrial, pilot plant and hazardous area applications.

See more

You may also like

Manufacturing

Compact vortex flow meter with local display

Read more
Mass Flow ONLINE specialises in low flow measurement and control, it proudly presents its new models in the LIQUI-VIEW Base series

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Britain's biotech potential (part I): world-class science, second-class support? The UK produces top-tier life sciences research, offers favourable conditions for early-stage investment and hosts a growing network of internationally competitive clusters. So why does the capital keep leaving?
  4. UK REACH reform falls short as industry warns of £500m+ compliance bill The UK chemicals industry has condemned the Government's long-awaited response to the UK REACH Alternative Transitional Registration model consultation, arguing it does little to support growth or innovation
  5. Sun Pharma to acquire Organon in $11.75bn deal, expanding global manufacturing and biosimilars reach The firm will acquire Organon in an all-cash $11.75bn transaction, creating a larger global pharma group with expanded manufacturing capacity, stronger women's health operations and a top-10 biosimilars position

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Compact vortex flow meter with local display

Mass Flow ONLINE specialises in low flow measurement and control, it proudly presents its new models in the LIQUI-VIEW Base series
Analysis

A clear view on higher flow rates

Check out the two new machine models for flow regulators, launched by Mass Flow Online
Analysis

Higher flow rates for mini Coriolis Flow Meters

<p>Bronkhorst Cori-Tech B.V. has released a new model in its series of compact Coriolis Mass Flow Meters/Controllers for accurate measurement and control of (very) low flow rates.</p>
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Britain's biotech potential (part II): world-class science, second-class support?

In part one, Manufacturing Chemist explored the UK’s world-class science base and early-stage investment appeal. In this second instalment, attention turns to the structural gaps that are limiting its ability to scale
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Finance

Sun Pharma to acquire Organon in $11.75bn deal, expanding global manufacturing and biosimilars reach

The firm will acquire Organon in an all-cash $11.75bn transaction, creating a larger global pharma group with expanded manufacturing capacity, stronger women's health operations and a top-10 biosimilars position
Analysis

Introducing Shimadzu’s MultiNA II: Redefining precision in life science analysis

Designed with users in mind, the MultiNA II MCE-301 is a fully automated microchip electrophoresis system designed to accelerate and simplify genetic analysis workflows in pharmaceutical and biopharmaceutical laboratories
Subscribe now